Filter Results:
(313)
Show Results For
- All HBS Web
(313)
- People (1)
- News (124)
- Research (147)
- Multimedia (13)
- Faculty Publications (95)
Show Results For
- All HBS Web
(313)
- People (1)
- News (124)
- Research (147)
- Multimedia (13)
- Faculty Publications (95)
- 23 Sep 2021
- News
The Innovation System Behind Moderna’s Covid-19 Vaccine
- 26 Feb 2020
- News
Alumni-Led Biotech Developing Vaccine to Combat Coronavirus
As reported in the Boston Globe, Stéphane Bancel (MBA 2000, AMP 170) and his firm Moderna Therapeutics are working with the National Institutes of Health (NIH) to develop a vaccine for coronavirus. Vials of its vaccine, the company told... View Details
- 17 Sep 2020
- News
6 questions that must be answered in the race for a vaccine
- February 2022 (Revised August 2022)
- Case
Defense Logistics Agency: Dynamic Vaccine Distribution at Scale
By: Hise Gibson, Gary P. Pisano, Pettis Kent and Michael Norris
Gibson, Hise, Gary P. Pisano, Pettis Kent, and Michael Norris. "Defense Logistics Agency: Dynamic Vaccine Distribution at Scale." Harvard Business School Case 622-078, February 2022. (Revised August 2022.)
- 29 Jan 2021
- News
How Influencers, Celebrities, and FOMO Can Win Over Vaccine Skeptics
- Article
America's Pharmacies Can Do a Lot More Vaccinations
By: Scott Duke Kominers and Alex Tabarrok
Kominers, Scott Duke, and Alex Tabarrok. "America's Pharmacies Can Do a Lot More Vaccinations." Bloomberg Opinion (February 17, 2021).
- September 2020 (Revised July 2021)
- Case
Moderna (A)
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer and Kerry Herman
In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19. The case explores how a company builds a digital organization, and leverages artificial intelligence and other digital... View Details
Keywords: COVID-19; Vaccine; Digital Organizations; Organizational Structure; Operations; Management; Health Pandemics; Research and Development; Goals and Objectives
Iansiti, Marco, Karim R. Lakhani, Hannah Mayer, and Kerry Herman. "Moderna (A)." Harvard Business School Case 621-032, September 2020. (Revised July 2021.)
- 15 Jun 2020
- News
Science, Business & Vaccine Development to Combat the Pandemic
- 02 Dec 2021
- News
La vaccination obligatoire : un bon point pour l'économie
- August 2021
- Teaching Note
Fair Park Covid-19 Mass Vaccination Site (A) and (B)
By: Willy Shih
Teaching Note for HBS Case Nos. 622-003 and 622-004. View Details
- 05 Jan 2021
- News
Retail pharmacy chains will face challenges for vaccine rollout
- Article
Ein Booster für die Pharmabranche [A Booster for the Pharmaceutical Industry]
By: Ariel Dora Stern, Timo Minssen, W. Nicholson Price, II and Christoph Grimpe
mRNA technology has just helped to develop vaccines against COVID-19. Now, like Apple's iOS, it could provide the basis for new innovation platforms. View Details
Keywords: mRNA; COVID-19; Vaccines; Health Care and Treatment; Health Pandemics; Innovation and Invention; Health Industry
Stern, Ariel Dora, Timo Minssen, W. Nicholson Price, II, and Christoph Grimpe. "Ein Booster für die Pharmabranche [A Booster for the Pharmaceutical Industry]." Harvard Business Manager (July 2022).
- 18 Aug 2020
- News
Vaccines Use Bizarre Stuff. We Need a Supply Chain Now.
- Article
Vaccines Use Bizarre Stuff. We Need a Supply Chain Now.
By: Scott Duke Kominers and Alex Tabarrok
Kominers, Scott Duke, and Alex Tabarrok. "Vaccines Use Bizarre Stuff. We Need a Supply Chain Now." Bloomberg Opinion (August 18, 2020).
- January 2021 (Revised March 2021)
- Case
Serum Institute of India (SII): Racing to Save Lives During a Pandemic
By: Rohit Deshpandé, Anjali Raina and Rachna Chawla
The CEO of Serum Institute of India (SII), a $12.8 billion Indian Family business is faced with a risky choice between principles and profit. SII is the largest manufacturer of vaccines in the world and Adar Poonawalla, the CEO and son of the founder has to decide how... View Details
Keywords: Business Ethics; Healthcare; COVID-19; Vaccines; Family Business; Ethics; Health Care and Treatment; Health Pandemics; Leadership; Corporate Accountability; Fairness; Growth and Development Strategy; Health Industry; India; South Asia
Deshpandé, Rohit, Anjali Raina, and Rachna Chawla. "Serum Institute of India (SII): Racing to Save Lives During a Pandemic." Harvard Business School Case 521-028, January 2021. (Revised March 2021.)
- 15 Jan 2021
- News